Growing Need for Nutritional Support Alongside GLP-1 Therapies The key drivers of the GLP-1 companion nutrition market is the increasing use of GLP-1based treatments for weight management and metabolic health
As the number of approved GLP-1 medications grows, clinicians will increasingly be able to choose from a menu of options, some of which may be especially appropriate for individual patients
If a meaningful share of the patients who started on Wegovy or Ozempic in the 2022 to 2024 wave have already discontinued, the installed base of recurring prescriptions is smaller than the volume data implies, and the forward revenue from that cohort is lower than a pure adherence model would project
Stroke There's so much strong evidence that GLP-1 receptor agonists help reduce the risk of stroke among people with type 2 diabetes that many guidelines, including those from the American Heart Association, recommend that people with type 2 diabetes take the drugs in addition to getting regular exercise, eating healthfully, quitting smoking, and avoiding alcohol
She is an assistant professor of internal medicine at UT Southwestern in Dallas
